Treatment guidelines for cerebral arteriovenous malformation microsurgery

Robert M. Starke; Ricardo J. Komotar; Brian Y. Hwang; Laura E. Fischer; Matthew C. Garrett; Marc L. Otten; E. Sander Connolly

doi:10.1080/02688690902977662

Treatment guidelines for cerebral arteriovenous malformation microsurgery

Robert M. Starke, Ricardo J. Komotar, Brian Y. Hwang, Laura E. Fischer, Matthew C. Garrett, Marc L. Otten, E. Sander Connolly

Research output: Contribution to journal › Review article › peer-review

51 Scopus citations

Abstract

The goal of cerebral arteriovenous malformation (AVM) treatment is to eliminate intracerebral hemorrhage risk and to preserve or maximize neurological functions of the patient. Interventional planning must determine the modality or combination of modalities with the greatest success rate according to patient characteristics, AVM architecture, and the capabilities of the treatment option to fulfill the goals of treatment. Although there is a lack of data from randomized trials to guide AVM management, microsurgery is a mainstay of therapy in patients receiving definitive intervention. In this paper, we review current guidelines for surgical planning, risk-benefit analysis, and prediction of outcome in AVM patients.

Original language	English (US)
Pages (from-to)	376-386
Number of pages	11
Journal	British Journal of Neurosurgery
Volume	23
Issue number	4
DOIs	https://doi.org/10.1080/02688690902977662
State	Published - Aug 1 2009
Externally published	Yes

Keywords

Arteriovenous malformation
Complication
Embolization
Outcome
Surgery

ASJC Scopus subject areas

Clinical Neurology
Surgery

Access to Document

10.1080/02688690902977662

Fingerprint Dive into the research topics of 'Treatment guidelines for cerebral arteriovenous malformation microsurgery'. Together they form a unique fingerprint.

Cite this

@article{3bbe5c27955b4c78bf2a87a3501bc78b,

title = "Treatment guidelines for cerebral arteriovenous malformation microsurgery",

abstract = "The goal of cerebral arteriovenous malformation (AVM) treatment is to eliminate intracerebral hemorrhage risk and to preserve or maximize neurological functions of the patient. Interventional planning must determine the modality or combination of modalities with the greatest success rate according to patient characteristics, AVM architecture, and the capabilities of the treatment option to fulfill the goals of treatment. Although there is a lack of data from randomized trials to guide AVM management, microsurgery is a mainstay of therapy in patients receiving definitive intervention. In this paper, we review current guidelines for surgical planning, risk-benefit analysis, and prediction of outcome in AVM patients.",

keywords = "Arteriovenous malformation, Complication, Embolization, Outcome, Surgery",

author = "Starke, {Robert M.} and Komotar, {Ricardo J.} and Hwang, {Brian Y.} and Fischer, {Laura E.} and Garrett, {Matthew C.} and Otten, {Marc L.} and Connolly, {E. Sander}",

year = "2009",

month = aug,

day = "1",

doi = "10.1080/02688690902977662",

language = "English (US)",

volume = "23",

pages = "376--386",

journal = "British Journal of Neurosurgery",

issn = "0268-8697",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - Treatment guidelines for cerebral arteriovenous malformation microsurgery

AU - Starke, Robert M.

AU - Komotar, Ricardo J.

AU - Hwang, Brian Y.

AU - Fischer, Laura E.

AU - Garrett, Matthew C.

AU - Otten, Marc L.

AU - Connolly, E. Sander

PY - 2009/8/1

Y1 - 2009/8/1

N2 - The goal of cerebral arteriovenous malformation (AVM) treatment is to eliminate intracerebral hemorrhage risk and to preserve or maximize neurological functions of the patient. Interventional planning must determine the modality or combination of modalities with the greatest success rate according to patient characteristics, AVM architecture, and the capabilities of the treatment option to fulfill the goals of treatment. Although there is a lack of data from randomized trials to guide AVM management, microsurgery is a mainstay of therapy in patients receiving definitive intervention. In this paper, we review current guidelines for surgical planning, risk-benefit analysis, and prediction of outcome in AVM patients.

AB - The goal of cerebral arteriovenous malformation (AVM) treatment is to eliminate intracerebral hemorrhage risk and to preserve or maximize neurological functions of the patient. Interventional planning must determine the modality or combination of modalities with the greatest success rate according to patient characteristics, AVM architecture, and the capabilities of the treatment option to fulfill the goals of treatment. Although there is a lack of data from randomized trials to guide AVM management, microsurgery is a mainstay of therapy in patients receiving definitive intervention. In this paper, we review current guidelines for surgical planning, risk-benefit analysis, and prediction of outcome in AVM patients.

KW - Arteriovenous malformation

KW - Complication

KW - Embolization

KW - Outcome

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=68849120601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849120601&partnerID=8YFLogxK

U2 - 10.1080/02688690902977662

DO - 10.1080/02688690902977662

M3 - Review article

C2 - 19637008

AN - SCOPUS:68849120601

VL - 23

SP - 376

EP - 386

JO - British Journal of Neurosurgery

JF - British Journal of Neurosurgery

SN - 0268-8697

IS - 4

ER -